Biotech Showcase™ 2016: Interview: Ergomed pursues shared-risk approach to help VC-backed biotechs

February 26, 2016
As well as providing high quality clinical development services, Ergomed is building a portfolio of co-development partnerships with pharma and biotech companies. CBO Andrew Mackie explains to Mike Ward, Informa’s global director of content for pharma insights, how the company is prepared to share the risks and rewards of drug development, leveraging its expertise and services in return for carried interest in the drugs under development. Find more videos and articles at http://www.partnering360.com/insight For more information on Biotech Showcase™, visit our webpage: http://www.ebdgroup.com/bts/index.php
Previous Video
Biotech Showcase™ 2016: Interview: Keryx reboots disappointing product launch
Biotech Showcase™ 2016: Interview: Keryx reboots disappointing product launch

Keryx Biopharmaceuticals CEO Greg Madison reveals to Mike Ward, global director of content for Informa's ph...

Next Video
Biotech Showcase™ 2016: Interview: BC Platforms making genomics data meaningful
Biotech Showcase™ 2016: Interview: BC Platforms making genomics data meaningful

BC Platforms CEO Tero Silvola explains to Mike Ward, global director of content for Informa's pharma insigh...